ReviewMedicina (Kaunas, Lithuania)2026

Glucagon-like Peptide-1 Receptor Agonists and Dual Incretin Therapies Across HFpEF and Cardiovascular Outcomes Trials in Patients with Obesity.

Andrej Belančić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.